Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pretax income is the income that a company earns before paying income taxes. Proteomics International Laboratories's pretax income for the
six
months ended in Dec. 2025 was $-4.03 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2025 was $-6.41 Mil.
Proteomics International Laboratories's pretax margin was -1,086.52%.
During the past 11 years, Proteomics International Laboratories's highest Pretax Margin was -99.03%. The lowest was -1091.91%. And the median was -190.35%.
Proteomics International Laboratories (OTCPK:PIQLF) Pre-Tax Income Explanation
Proteomics International Laboratories's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as
During the past 11 years, Proteomics International Laboratories's highest Pretax Margin was -99.03%. The lowest was -1091.91%. And the median was -190.35%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proteomics International Laboratories Pre-Tax Income Related Terms
Proteomics International Laboratories Pre-Tax Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proteomics International Laboratories Pre-Tax Income Chart
PIQLF vs VRTX, REGN, ALNY: Pre-Tax Income Comparison
For the Biotechnology subindustry, Proteomics International Laboratories's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Proteomics International Laboratories Pre-Tax Income vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Proteomics International Laboratories's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Proteomics International Laboratories's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-6.41 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proteomics International Laboratories (PIQLF) has a Pre-Tax Income of $-6.41 Mil as of Dec. 2025. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Proteomics International Laboratories and its competitors.
Is Proteomics International Laboratories' Pre-Tax Income too high?
Proteomics International Laboratories' current Pre-Tax Income is $-6.41 Mil. Overall, Proteomics International Laboratories has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Proteomics International Laboratories' Pre-Tax Income compare to VRTX and REGN?
Proteomics International Laboratories' Pre-Tax Income of $-6.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Biotechnology company?
A good Pre-Tax Income depends on the Biotechnology industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Proteomics International Laboratories and its competitors. Proteomics International Laboratories's current Pre-Tax Income is $-6.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteomics International Laboratories stock overvalued right now?
Proteomics International Laboratories (PIQLF) has a current Pre-Tax Income of $-6.41 Mil. The stock's GF Value™ is $0.66, compared to a current price of $0.26 — trading 60.6% below its estimated fair value. The current Pre-Tax Income is $-6.41 Mil. Proteomics International Laboratories' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Proteomics International Laboratories (PIQLF), the current Pre-Tax Income is $-6.41 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Proteomics International Laboratories (PIQLF) Overvalued in 2026?
Based on GuruFocus' analysis, Proteomics International Laboratories stock appears to be undervalued.
The current stock price of $0.26 is trading 60.6% below its estimated GF Value™ of $0.66.
Key valuation signals for PIQLF:
Pre-Tax Income: $-6.41 Mil
GF Value™: $0.66 vs. price of $0.26 (60.6% below fair value)
No single metric tells the full story. See the PIQLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Proteomics International Laboratories Business Description
Proteomics International Laboratories Ltd is a biological research and drug discovery company. It is a pioneering medical technology company operating at the forefront of predictive diagnostics and precision medicine. The Company specialises in proteomics-the industrial-scale study of the structure and function of proteins. Its pipeline includes Promarker, Pipeline PromarkerD, PromarkerEndo, PromarkerEso, and OxiDx.
31GF Score
Get the complete analysis for PIQLF
Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PIQLF has been successfully added to your 
